James Dennewill

Chief Operating Officer at SPYGLASS PHARMA, INC.

Net worth: 3 M $ as of 30/08/2026

45 year

Consumer Services

Health Technology

Profile

James Dennewill is the Chief Operating Officer at SpyGlass Pharma, Inc. since 2021, with employment at the company starting in 2019.
Formerly, Mr. Dennewill was the Chief Operating Officer at Cianna Medical, Inc. Education includes an undergraduate degree from The California State University and an MBA from Yale School of Management.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
SPYGLASS PHARMA, INC. 0.29%	04/02/2026	96,022 ( 0.29% )	3 M $	30/08/2026

James Dennewill active positions

Companies	Position	Start
SPYGLASS PHARMA, INC.	Chief Operating Officer	30/09/2021

All active positions of James Dennewill

Former positions of James Dennewill

Companies	Position	End
Cianna Medical, Inc. Cianna Medical, Inc. Medical SpecialtiesHealth Technology Manufactures and designs medical products for treatment of early-stage breast cancer in women	Chief Operating Officer	-

See the detail of James Dennewill's experience

Training of James Dennewill

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of James Dennewill's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
The California State University The California State University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Cianna Medical, Inc. Cianna Medical, Inc. Medical SpecialtiesHealth Technology Manufactures and designs medical products for treatment of early-stage breast cancer in women	Health Technology
Yale School of Management Yale School of Management Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
SpyGlass Pharma Inc SpyGlass Pharma Inc BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops IOL-mounted drug delivery platform for glaucoma patients	Health Technology